HIGHLIGHTS
- who: Jie Mao from the (UNIVERSITY) have published the research work: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety, in the Journal: (JOURNAL)
SUMMARY
The anti-tumor activity of melittin nano-liposomes was investigated both in_vitro and in_vivo models (Additional file 1: Materials and methods). The authors found that five hepatic carcinoma cell lines used (Bel-7402, BMMC-7721, HepG2, LM-3, and Hepa 1-6 cells) were sensitive to melittin nano-liposomes, and the IC50 value was close to melittin, ranging from 1.44 to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.